source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[biological replicate]	characteristics[individual]	assay name	Technology Type	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[cleavage agent details]	comment[label]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	factor value[disease]
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	1	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	2	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	3	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	4	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	5	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	6	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	7	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	8	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	9	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	10	run 1	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	11	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	12	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	13	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	14	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	15	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	16	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	17	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	18	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	19	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	20	run 2	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	21	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	22	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	23	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	24	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	25	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	26	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	27	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	28	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	29	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	30	run 3	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	31	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	32	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	33	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	34	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	35	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	36	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	37	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	38	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	39	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	40	run 4	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	41	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	42	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	43	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	44	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	45	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	46	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	47	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	48	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	49	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	50	run 5	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	51	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	52	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	53	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	54	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	55	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	56	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	57	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	58	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	59	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	60	run 6	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	61	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	62	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	63	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	64	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	65	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	66	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	67	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	68	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	69	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	70	run 7	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	71	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	72	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	73	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	74	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	75	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	76	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	77	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	78	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	79	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	80	run 8	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	81	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	82	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	83	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	84	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	85	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	86	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	87	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	88	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	89	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	90	run 9	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	91	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	92	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	93	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	94	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	95	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	96	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	97	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	98	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	99	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	100	run 10	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	101	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	102	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	103	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	104	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	105	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	106	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	107	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	108	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	109	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	110	run 11	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	111	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	112	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	113	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	114	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	115	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	116	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	117	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	118	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	119	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	120	run 12	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	121	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	122	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	123	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	124	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	125	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	126	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	127	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	128	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	129	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	130	run 13	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	131	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	132	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	133	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	134	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	135	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	136	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	137	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	138	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	139	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	140	run 14	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	141	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	142	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	143	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	144	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	145	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	146	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	147	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	148	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	149	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	150	run 15	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	151	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	152	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	153	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	154	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	155	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	156	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	157	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	158	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	159	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	160	run 16	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	161	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	162	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	163	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	164	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	165	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	166	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	167	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	168	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	169	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	170	run 17	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	171	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	172	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	173	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	174	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	175	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	176	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	177	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	178	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	179	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	180	run 18	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	181	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	182	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	183	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	184	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	185	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	186	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	187	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	188	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	189	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	190	run 19	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	191	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	192	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	193	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	194	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	195	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	196	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	197	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	198	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	199	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	200	run 20	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	201	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	202	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	203	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	204	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	205	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	206	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	207	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	208	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	209	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	210	run 21	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	211	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	212	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	213	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	214	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	215	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	216	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	217	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	218	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	219	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	220	run 22	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	221	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	222	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	223	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	224	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	225	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	226	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	227	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	228	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	229	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	230	run 23	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	231	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	232	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	233	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	234	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	235	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	236	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	237	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	238	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	239	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	240	run 24	proteomic profiling by mass spectrometry	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected